PeDRA 2025Abstract 004Observational study
Efficacy and safety of moxifloxacin in pediatric hidradenitis suppurativa
results from the Canadian Multidisciplinary Registry of Pediatric HS
Rahmani A, Dienes S, Lara-Corrales I, Levy R, Alhusayen R, Barnett A, Croitoru D, George R, Hamilton J, Johnson K, Joseph M, Palmer L, Mirza R, Piguet V, Sangha N, Wong CL, Sibbald C
PeDRA Annual Conference 2025Minneapolis, 9–11 Oct 2025 · published in JID 9 Mar 2026
Topics: Hidradenitis suppurativaPediatric dermatology
Abstract
The abstract’s text is on the JID website.
DOI 10.1016/s0022-202x(26)00545-2 · Not in PubMed: details from Crossref